BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1327287)

  • 1. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
    Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
    Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell membrane expression and functional role of the p75 subunit of interleukin-2 receptor in lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Pizzolo G; Bulian P; Masciarelli M; Feruglio C; Agostini C; Raimondi R; Chisesi T; Semenzato G
    Blood; 1990 Nov; 76(10):2080-5. PubMed ID: 2146981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Cassatella MA; Raimondi R; Cerutti A; Enthammer C; Facco M; Agostini C; Semenzato G
    Br J Haematol; 1996 Feb; 92(2):308-14. PubMed ID: 8602990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disorders.
    Hoshino S; Oshimi K; Teramura M; Mizoguchi H
    Blood; 1991 Dec; 78(12):3232-40. PubMed ID: 1835892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Facco M; Siviero M; Galvan S; Piazza F; Perin A; Agostini C; Semenzato G
    Blood; 2000 Jul; 96(2):647-54. PubMed ID: 10887130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.
    Semenzato G; Zambello R; Starkebaum G; Oshimi K; Loughran TP
    Blood; 1997 Jan; 89(1):256-60. PubMed ID: 8978299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders.
    Trentin L; Zambello R; Agostini C; Siviero F; Adami F; Marcolongo R; Raimondi R; Chisesi T; Pizzolo G; Semenzato G
    Blood; 1993 Feb; 81(3):752-8. PubMed ID: 8381309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Ciccone E; Bulian P; Agostini C; Moretta A; Moretta L; Semenzato G
    Blood; 1993 May; 81(9):2381-5. PubMed ID: 8481518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that tumor necrosis factor alpha (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor.
    Menegazzi R; Cramer R; Patriarca P; Scheurich P; Dri P
    Blood; 1994 Jul; 84(1):287-93. PubMed ID: 8018924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
    Brennan FM; Gibbons DL; Mitchell T; Cope AP; Maini RN; Feldmann M
    Eur J Immunol; 1992 Jul; 22(7):1907-12. PubMed ID: 1320571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro.
    Delwel R; van Buitenen C; Löwenberg B; Touw I
    Blood; 1992 Oct; 80(7):1798-803. PubMed ID: 1382704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Facco M; Carollo D; Cabrelle A; Tosoni A; Cannas G; Nicolardi L; Agostini C; Semenzato G
    Br J Haematol; 2003 Mar; 120(5):765-73. PubMed ID: 12614207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.
    Naume B; Shalaby R; Lesslauer W; Espevik T
    J Immunol; 1991 May; 146(9):3045-8. PubMed ID: 1707931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cabrelle A; Trentin L; Agostini C; Semenzato G; Viola A
    Leukemia; 2004 Apr; 18(4):771-6. PubMed ID: 15044927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
    Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
    Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K; Fransen L; Ceuppens JL
    Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.